Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis. - Wikidata - wikimedia - TriplyDB

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

http://www.wikidata.org/entity/Q35541055

about

Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats Development of daptomycin for gram-positive infections.Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination Daptomycin (LY146032) treatment of experimental enterococcal endocarditis Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin Current perspectives on glycopeptide resistance.Daptomycin.Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s Resistance to vancomycin and teicoplanin: an emerging clinical problem.Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?Comparative activity of daptomycin and teicoplanin against enterococci isolated from blood and urine.Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.Daptomycin: a novel agent for Gram-positive infections.

P2860

Q28330353-EEF9D40B-C535-4772-867D-AE2FB03D66FD Q33920377-595873C2-8272-4601-B233-6B9E9A8095FB Q35285000-A999E91E-9DF9-40E0-90D8-481DC5E69910 Q35309352-EBC7EB47-C72E-4C0F-BFFB-A4C57DEFF57B Q35355587-D491B926-11D1-4A09-BFB8-0E8C02698172 Q35368590-60E9BA16-B81F-4CF5-9F4F-74E134A00FF1 Q35637066-5C12DD94-57A3-40F0-9D7A-974914A9741B Q36473436-DE3CFF4B-A4D2-45F7-8350-CC7AEFE9D119 Q36636341-0D5AA83A-CC82-4019-AC40-500BAF69BBB0 Q37180294-E4CC9A1C-522F-4BA6-B924-03B3DF4849E8 Q41831269-ED4B63B2-7065-47EB-A678-5269FD99B5D6 Q44672108-C97F49AF-E209-49B6-BBD6-29234DB08535 Q53852746-B69ED5E8-83D2-4928-A015-2285B9DD353C

P2860

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

http://www.wikidata.org/entity/Q35541055

description

1987 nî lūn-bûn

@nan

1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@ast

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@en

type

label

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@ast

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@en

prefLabel

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@ast

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@en

P1433

Q35541055-5D53B54F-2B41-43DA-AA14-C52062B69B61

P1476

Q35541055-96FEA07F-8982-4FB0-B6FC-235F814C4D04

P2093

Q35541055-4A77BFD1-311C-4FBD-A30B-D82730C47A96

Q35541055-906252F2-C9F1-4D73-865C-ADD321AD3556

Q35541055-B31E92C6-8D72-4B67-81B0-E3B285EFD83A

Q35541055-F0953877-5B2B-41C5-BAFD-4C7C0505F4D7

P2860

Q35541055-196648D0-E038-48F0-8E0D-A268C0F7B61E

Q35541055-21634A42-37F8-4C7F-B2DD-3FE972FF8F42

Q35541055-33DABA84-9C8D-4AD7-ADF7-F04CDC33BBA9

Q35541055-68F673B3-AE60-4FE0-969F-733A88D5F603

Q35541055-77267E18-2C1E-41B1-B37A-1C4F7D7D0DB1

Q35541055-7E0BC81F-94C9-4093-85E8-0EE7C6F5847B

Q35541055-A0B3831C-AA5F-4CDE-ABD5-C195F81EDE2C

Q35541055-B1216D11-08BD-4781-A35A-E5DE1FB6D81B

Q35541055-C94383DC-354C-461D-B3F9-F373A841A74C

P304

Q35541055-64972232-005D-48DE-B196-A0FF8902728A

P31

Q35541055-53FDDEE7-1685-40A2-8705-46A8848DCEF4

P356

Q35541055-7F51FE9B-7A88-4FAC-AD60-C0D76C18F3C9

P407

Q35541055-66CD419F-0C5B-4EB0-92F6-F0673ADBA6A4

P433

Q35541055-7DE1539D-EB95-41C7-B64D-1847BD97F1E2

P478

Q35541055-3E406021-3762-49E2-B89D-B47D50070769

P577

Q35541055-B28B920B-6506-4421-BC9D-19DDB5148A3C

P5875

Q35541055-11578C91-F1D7-41EA-BAE8-C34B8F94D9A5

P698

Q35541055-AFE4CE1F-278C-4CD5-B3F6-605B317A6603

P932

Q35541055-43761916-F689-46B9-A969-E731003CDF43

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

@en

P2093

Andriole VT

http://www.w3.org/2001/XMLSchema#string

Johnson MA

http://www.w3.org/2001/XMLSchema#string

Miniter PM

http://www.w3.org/2001/XMLSchema#string

Patterson TF

http://www.w3.org/2001/XMLSchema#string

P2860

Pyelonephritis. I. Observations on the course of chronic non-obstructed enterococcal infection in the kidnev of the rat.

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Rifampin, ampicillin, streptomycin, and their combinations in the treatment of enterococcal pyelonephritis in rats.

Methodological variation in antibiotic synergy tests against enterococci.

Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella.

Effect of water diuresis on chronic pyelonephritis.

Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in rats.

Optimal therapy for enterococcal endocarditis.

A method for testing for synergy with any number of agents.

P304

1199-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.31.8.1199

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1987-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20336544

http://www.w3.org/2001/XMLSchema#string

P698

2820299

http://www.w3.org/2001/XMLSchema#string

P932

174903

http://www.w3.org/2001/XMLSchema#string